Original case report of amyloidosis with pleural involvement: echocardiographic interest for diagnosis;Un cas original d'amylose pleurale : apport de l'échocardiographie au diagnostic

Revue de Medecine Interne

Volumn 27, Issue 10, 2006, Pages 794-796

  Roubille, F ^a   Billotet, C ^b   Roubille, C ^c  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b hopital Saint Jean   (France)

^c HÔPITAL SAINT ELOI   (France)

Author keywords

Amyloidosis; Echocardiography; Pleural involvement; Restrictive cardiomyopathy

Indexed keywords

DEXAMETHASONE; MELPHALAN;

AGED; AMYLOIDOSIS; ARTICLE; CASE REPORT; DIAGNOSTIC VALUE; DIGESTIVE SYSTEM EXAMINATION; ECHOCARDIOGRAPHY; HEART FAILURE; HUMAN; MALE; PLEURA EFFUSION; RESTRICTIVE CARDIOMYOPATHY;

AGED; AMYLOIDOSIS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; CARDIOMYOPATHY, RESTRICTIVE; DEXAMETHASONE; DRUG THERAPY, COMBINATION; ECHOCARDIOGRAPHY; HUMANS; MALE; MELPHALAN; PLEURAL EFFUSION; TREATMENT OUTCOME;

EID: 33749141241     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2006.05.004     Document Type: Article

References (13)

1. Kawakami A., Origuchi T., Eguchi K., Tanaka F., Migita K., Honda S., et al. Clinical outcome and survival of secondary (AA) amyloidosis. Clin. Exp. Rheumatol. 21 (2003) 343-346
2. Dispenzieri A., Kyle R.A., Gertz M.A., Therneau T.M., Miller W.L., Chandrasekaran K., et al. Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins. Lancet 24 361 (2003) 1787-1789
3. Gertz M.A., and Kyle R.A. Secondary systemic amyloidosis: response and survival in 64 patients. Medicine (Baltimore) 70 (1991) 246-256
4. Kyle R.A., and Bayrd E.D. Amyloidosis: review of 236 cases. Medicine (Baltimore) 54 (1975) 271-299
5. Graham D.R., and Ahmad D. Amyloidosis with pleural involvement. Eur. Resp. J. 1 (1988) 571-572
6. Berk J.L., Keane J., Seldin D.C., Sanchorawala V., Koyama J., Dember L.M., et al. Persistent pleural effusions in primary systemic amyloidosis: etiology and prognosis. Chest 124 (2003) 969-977
7. Roux C.H., Breuil V., Brocq O., and Euller-Ziegler L. Pleural amyloidosis as the first sign of IgD multiple myeloma. Clin. Rheumatol. 24 (2005) 294-295
8. Kyle R.A., Gertz M.A., Greipp P.R., Witzig T.E., Lust J.A., Lacy M.Q., et al. A trial of three regimens for primary amyloidosis : colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. N. Engl. J. Med. 336 (1997) 1202-1207
9. Skinner M., Sanchorawala V., Seldin D.C., Dember L.M., Falk R.H., Berk J.L., et al. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann. Intern. Med. 140 (2004) 85-93
10. Sallach J.A., and Klein A.L. Tissue Doppler imaging in the evaluation of patients with cardiac amyloidosis. Curr. Opin. Cardiol. 19 (2004) 464-471
11. Modesto K.M., Dispenzieri A., Cauduro S.A., Lacy M., Khandheria B.K., Pellikka P.A., et al. Left atrial myopathy in cardiac amyloidosis: implications of novel echocardiographic techniques. Eur. Heart J. 26 (2005) 173-179
12. Ogiwara F., Koyama J., Ikeda S., Kinoshita O., and Falk R.H. Comparison of the strain Doppler echocardiographic features of familial amyloid polyneuropathy (FAP) and light-chain amyloidosis. Am J Cardiol. 15 95 (2005) 538-540
13. Palladini G., Campana C., Klersy C., Balduini A., Vadacca G., Perfetti V., et al. Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis. Circulation 20 107 (2003) 2440-2445